Using MRI, we measured disease activity and brain atrophy in nine multiple sclerosis patients treated with autologous hematopoietic stem cell transplantation (AHSCT) for a mean follow up of 63 months. We show that AHSCT is associated to a longlasting suppression of inflammation and to a marked decrease of the rate of brain atrophy after the second year following treatment. Multiple Sclerosis 2007; 13 : 1068—1070. http://msj.sagepub.com
Blanco Y. , Saiz A. , Carreras E. , Graus F.Autologous haematopoietic stem-cell transplantation for multiple sclerosis . Lancet Neurol2005; 4: 54—63 .
2.
Chen JT , Collins DL , Atkins HL , Freedman MS , Galal A. , Arnold DLBrain atrophy after immunoablation and stem cell transplantation in multiple sclerosis . Neurology2006; 66: 1935—37 .
3.
Inglese M. , Mancardi GL , Pagani E. , Rocca MA , Murialdo A. et al. Brain tissue loss occurs after suppression of enhancement in patients with multiple sclerosis treated with autologous haematopoietic stem cell transplantation . J Neurol Neurosurg Psychiatry2004; 75: 643—44 .
4.
Miller DH , Barkhof F. , Frank JA , Parker GJ , Thompson AJMeasurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance . Brain2002 ; 125: 1676—95 .
5.
Fisher E. , Rudick RA , Simon JH , Cutter G. , Baier M. , Lee JC et al. Eight-year follow-up study of brain atrophy in patients with MS . Neurology2002; 59: 1412—20 .
6.
Mancardi GL , Saccardi R. , Filippi M. , Gualandi F. , Murialdo A. , Inglese M. et al. Autologous hematopoietic stem cell transplantation suppresses Gd-enhanced MRI activity in MS . Neurology2001; 57: 62—68 .
7.
Smith SM , Zhang Y. , Jenkinson M. , Chen J. , Matthews PM , Federico A. et al. Accurate, robust, and automated longitudinal and cross-sectional brain change analysis . Neuroimage2002; 17: 479—89 .
8.
Trapp BD , Peterson J. , Ransohoff RM , Rudick R. , Mork S. , Bo L.Axonal transection in the lesions of multiple sclerosis . N Engl J Med1998; 338: 278—85 .
9.
Kutzelnigg A. , Lucchinetti CF , Stadelman C. , Bruck W. , Rauschka H. , Bergmann M. et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis . Brain2005; 128: 2705—12 .
10.
Jager HR , Williams EJ , Savage DG , Rule SA , Hajnal JV , Sikora K. et al. Assessment of brain changes with registered MR before and after bone marrow transplantation for chronic myeloid leukemia . AJNR Am J Neuroradiol1996; 17: 1275—82 .
11.
Coles AJ , Cox A. , Le Page E. , Jones J. , Trip SA , Deans J. et al. The window of therapeutic opportunity in multiple sclerosis: evidence from monoclonal antibody therapy . J Neurol2006; 253: 98—108 .
